BMP-7 for use in treating neointimal hyperplasia
US8741840B2 · kind B2 · utility
0Cited by
8References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2009 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Mar 31, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to prevention and treatment of vascular sclerosis, vascular calcification (VC) and neointimal hyperplasia using a morphogen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.